Correlation Between Agios Pharm and Relay Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Relay Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Relay Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Relay Therapeutics, you can compare the effects of market volatilities on Agios Pharm and Relay Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Relay Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Relay Therapeutics.

Diversification Opportunities for Agios Pharm and Relay Therapeutics

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Agios and Relay is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Relay Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relay Therapeutics and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Relay Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relay Therapeutics has no effect on the direction of Agios Pharm i.e., Agios Pharm and Relay Therapeutics go up and down completely randomly.

Pair Corralation between Agios Pharm and Relay Therapeutics

Given the investment horizon of 90 days Agios Pharm is expected to generate 1.25 times more return on investment than Relay Therapeutics. However, Agios Pharm is 1.25 times more volatile than Relay Therapeutics. It trades about 0.31 of its potential returns per unit of risk. Relay Therapeutics is currently generating about -0.25 per unit of risk. If you would invest  4,630  in Agios Pharm on August 31, 2024 and sell it today you would earn a total of  1,236  from holding Agios Pharm or generate 26.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Agios Pharm  vs.  Relay Therapeutics

 Performance 
       Timeline  
Agios Pharm 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Agios Pharm are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating forward indicators, Agios Pharm displayed solid returns over the last few months and may actually be approaching a breakup point.
Relay Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Relay Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Agios Pharm and Relay Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Agios Pharm and Relay Therapeutics

The main advantage of trading using opposite Agios Pharm and Relay Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Relay Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relay Therapeutics will offset losses from the drop in Relay Therapeutics' long position.
The idea behind Agios Pharm and Relay Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules